These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29274774)

  • 21. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.
    Weller RO; Cohen NR; Nicoll JA
    Panminerva Med; 2004 Dec; 46(4):239-51. PubMed ID: 15876980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
    Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
    Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of transcranial magnetic stimulation in vascular dementia.
    Pennisi G; Ferri R; Cantone M; Lanza G; Pennisi M; Vinciguerra L; Malaguarnera G; Bella R
    Dement Geriatr Cogn Disord; 2011; 31(1):71-80. PubMed ID: 21242688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular factors in dementia: an overview.
    Decarli C
    J Neurol Sci; 2004 Nov; 226(1-2):19-23. PubMed ID: 15537513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoreactivity induced by acetazolamide in patients with vascular dementia versus Alzheimer's disease.
    Likitjaroen Y; Suwanwela NC; Phanthumchinda K
    J Neurol Sci; 2009 Aug; 283(1-2):32-5. PubMed ID: 19375084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From neuronal and vascular impairment to dementia.
    De Deyn PP; Goeman J; Engelborghs S; Hauben U; D'Hooge R; Baro F; Pickut BA
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():17-24. PubMed ID: 10338104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways.
    Giuliani D; Bitto A; Galantucci M; Zaffe D; Ottani A; Irrera N; Neri L; Cavallini GM; Altavilla D; Botticelli AR; Squadrito F; Guarini S
    Neurobiol Aging; 2014 Mar; 35(3):537-47. PubMed ID: 24094579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic applications of lipid-coated microbubbles.
    Unger EC; Porter T; Culp W; Labell R; Matsunaga T; Zutshi R
    Adv Drug Deliv Rev; 2004 May; 56(9):1291-314. PubMed ID: 15109770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter clinicopathological correlation in dementia.
    Victoroff J; Mack WJ; Lyness SA; Chui HC
    Am J Psychiatry; 1995 Oct; 152(10):1476-84. PubMed ID: 7573587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia.
    Luca M; Luca A; Calandra C
    Oxid Med Cell Longev; 2015; 2015():504678. PubMed ID: 26301043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease. Part I: Pathology, diagnosis and screening.
    Davey DA
    Neurodegener Dis Manag; 2014; 4(3):253-9. PubMed ID: 25095819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery may help detect and treat Alzheimer's.
    Health News; 2004 Sep; 10(9):11. PubMed ID: 15597449
    [No Abstract]   [Full Text] [Related]  

  • 35. Making the diagnosis of mixed and non-Alzheimer's dementias.
    Hansen LA; Crain BJ
    Arch Pathol Lab Med; 1995 Nov; 119(11):1023-31. PubMed ID: 7487402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of transcranial ultrasound in predicting Alzheimer's disease risk.
    Tomek A; Urbanová B; Hort J
    J Alzheimers Dis; 2014; 42 Suppl 4():S365-74. PubMed ID: 25298200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathology of Alzheimer's disease.
    Blass JP; Ko L; Wisniewski HM
    Psychiatr Clin North Am; 1991 Jun; 14(2):397-420. PubMed ID: 2062726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.
    Habtemariam S
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific targeting of human inflamed endothelium and in situ vascular tissue transfection by the use of ultrasound contrast agents.
    Barreiro O; Aguilar RJ; Tejera E; Megías D; de Torres-Alba F; Evangelista A; Sánchez-Madrid F
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):997-1005. PubMed ID: 19679288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A vascular connection to Alzheimer's disease.
    Rhodin JA; Thomas T
    Microcirculation; 2001 Aug; 8(4):207-20. PubMed ID: 11528529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.